MX2022006407A - Composiciones bacterianas diseñadas y usos de estas. - Google Patents

Composiciones bacterianas diseñadas y usos de estas.

Info

Publication number
MX2022006407A
MX2022006407A MX2022006407A MX2022006407A MX2022006407A MX 2022006407 A MX2022006407 A MX 2022006407A MX 2022006407 A MX2022006407 A MX 2022006407A MX 2022006407 A MX2022006407 A MX 2022006407A MX 2022006407 A MX2022006407 A MX 2022006407A
Authority
MX
Mexico
Prior art keywords
bacterial compositions
designed
useful
designed bacterial
dysbiosis
Prior art date
Application number
MX2022006407A
Other languages
English (en)
Inventor
Matthew R Henn
David Cook
Marin Vulic
Madhumitha Nandakumar
Liyang Diao
Sumon Datta
Asuncion Martinez
Sheri Lynn Simmons
Christopher B Ford
Divya Balasubramanian
Ambar Piña
Meghan Chafee
Edward J O''brien
Lata Jayaraman
Original Assignee
Seres Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seres Therapeutics Inc filed Critical Seres Therapeutics Inc
Publication of MX2022006407A publication Critical patent/MX2022006407A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

En el presente documento se proporcionan composiciones bacterianas que son útiles para tratar y prevenir complicaciones y efectos secundarios asociados con una enfermedad o trastorno, como los asociados con la disbiosis del tracto gastrointestinal. Las composiciones bacterianas descritas en el presente documento están diseñadas para exhibir una o más características funcionales que son útiles para el tratamiento de dichas enfermedades y trastornos.
MX2022006407A 2019-11-27 2020-11-25 Composiciones bacterianas diseñadas y usos de estas. MX2022006407A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962941534P 2019-11-27 2019-11-27
PCT/US2020/062440 WO2021108728A1 (en) 2019-11-27 2020-11-25 Designed bacterial compositions and uses thereof

Publications (1)

Publication Number Publication Date
MX2022006407A true MX2022006407A (es) 2022-08-25

Family

ID=76130424

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022006407A MX2022006407A (es) 2019-11-27 2020-11-25 Composiciones bacterianas diseñadas y usos de estas.

Country Status (10)

Country Link
US (1) US20230125810A1 (es)
EP (1) EP4064862A1 (es)
JP (1) JP2023505098A (es)
KR (1) KR20220120573A (es)
CN (1) CN115175575A (es)
AU (1) AU2020394211A1 (es)
BR (1) BR112022010411A2 (es)
CA (1) CA3159711A1 (es)
MX (1) MX2022006407A (es)
WO (1) WO2021108728A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2022312473A1 (en) * 2021-07-10 2024-02-29 Microba Ip Pty Ltd Compositions and methods for treating disease ii
WO2023141347A2 (en) * 2022-01-24 2023-07-27 Gusto Global, Llc Single-loci and multi-loci targeted single point amplicon fragment sequencing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004104175A2 (en) * 2003-05-14 2004-12-02 University Of Georgia Research Foundation, Inc. Probiotic bacteria and methods
US8906668B2 (en) * 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
CN110917220A (zh) * 2013-02-04 2020-03-27 赛里斯治疗公司 治疗组合物及其使用方法
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
KR20180083894A (ko) * 2015-11-24 2018-07-23 세레스 테라퓨틱스, 인코포레이티드 설계된 박테리아 조성물
AU2017234120A1 (en) * 2016-03-14 2018-09-20 Holobiome, Inc. Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system
US10507221B2 (en) * 2017-11-09 2019-12-17 Vedanta Biosciences, Inc. Compositions and methods for the treatment of allergy

Also Published As

Publication number Publication date
CN115175575A (zh) 2022-10-11
JP2023505098A (ja) 2023-02-08
BR112022010411A2 (pt) 2022-08-23
US20230125810A1 (en) 2023-04-27
EP4064862A1 (en) 2022-10-05
CA3159711A1 (en) 2021-06-03
WO2021108728A1 (en) 2021-06-03
AU2020394211A1 (en) 2022-07-14
KR20220120573A (ko) 2022-08-30

Similar Documents

Publication Publication Date Title
WO2019227085A8 (en) Designed bacterial compositions and uses thereof
MX2021010868A (es) Bacteria de la familia christensenellaceaeas en la prevencion y/o tratamiento de enfermedades inflamatorias cronicas y/o enfermedades gastrointestinales inflamatorias y/o canceres.
IL291460A (en) Bacterial strains, their compositions and their use in the treatment of gastrointestinal disorders
PH12018501221A1 (en) Mixture of hmos
EP3584308A3 (en) Compositions and methods
EP4331679A3 (en) Compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
EP2440210A4 (en) METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
IL291445A (en) Bacterial strains, their compositions and their use in the treatment of gastrointestinal disorders
CA3045666A1 (en) Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices
MX2019006864A (es) Tratamiento de una enfermedad del tracto gastrointestinal con un inhibidor de factor de necrosis tumoral (tnf).
BR112022000875A2 (pt) Métodos e produtos para tratamento de distúrbios gastrointestinais
WO2018084531A3 (ko) 골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
WO2009064819A3 (en) Compositions for the treatment of gastrointestinal inflammation
WO2017053868A8 (en) C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
WO2017139697A8 (en) Bacteria engineered to treat diseases associated with hyperammonemia
WO2015143447A3 (en) Methods for treating neurological disorders
MX2022006407A (es) Composiciones bacterianas diseñadas y usos de estas.
MX2021007260A (es) Inhibidores de la vía de cinasa janus 1 (jak1) para el tratamiento de enfermedades gastrointestinales.
EP3818085A4 (en) COMPOSITIONS AND THEIR USES FOR THE TREATMENT OF DISEASES OR DISORDERS
MX2021003224A (es) Combinacion de probioticos para el tratamiento de trastornos gastrointestinales relacionados con la inflamacion.
MX2023006146A (es) Composiciones bacterianas diseñadas para tratar la enfermedad de injerto contra huésped.
MX2022007285A (es) Compuestos, polimeros, dispositivos y usos de los mismos.
MX2022011550A (es) Composiciones y métodos para inhibir la expresión de angptl3.
MX2020001256A (es) Compuestos para la prevencion y el tratamiento de trastornos medicos y usos de los mismos.
PH12021550121A1 (en) Methods of treating hfpef employing dapagliflozin and compositions comprising the same